↓ Skip to main content

Pancreatic cancer treatment with targeted therapies: are we there yet?

Overview of attention for article published in European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] NLMUID: 9717360, January 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pancreatic cancer treatment with targeted therapies: are we there yet?
Published in
European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] NLMUID: 9717360, January 2022
DOI 10.26355/eurrev_202201_27861
Pubmed ID
Authors

O Ngozi Nwaefulu, S Rao Sagineedu, M Kaisarul Islam, J Stanslas

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 23%
Researcher 2 15%
Student > Doctoral Student 1 8%
Student > Bachelor 1 8%
Other 1 8%
Other 0 0%
Unknown 5 38%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 15%
Biochemistry, Genetics and Molecular Biology 2 15%
Veterinary Science and Veterinary Medicine 1 8%
Nursing and Health Professions 1 8%
Medicine and Dentistry 1 8%
Other 1 8%
Unknown 5 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 February 2022.
All research outputs
#22,774,430
of 25,392,582 outputs
Outputs from European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] NLMUID: 9717360
#1,884
of 3,194 outputs
Outputs of similar age
#439,918
of 515,332 outputs
Outputs of similar age from European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] NLMUID: 9717360
#59
of 89 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,194 research outputs from this source. They receive a mean Attention Score of 3.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 515,332 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.